Point-of-care testing is performed near the patient and leads directly to diagnostic and therapeutic decisions. Hospital-based point-of-care testing (POCT) products are used in laboratories, operating theatres, accident & emergency departments and hospital wards. They include large core laboratory instruments including pre- and post-analytical platforms that prepare and store samples and work alongside analytical systems that produce the test result. The products also include smaller instruments for use throughout the hospital, including professional glucose meters, coagulation monitoring meters, blood gas analyzers and meters for cardiac and thrombotic markers. These hospital-based POC tests are for certain applications is a useful complement to conventional laboratory testing. POCT are used to diagnose and monitor conditions such as diabetes, heart failure, Down’s Syndrome, infertility, thyroid and liver disease as well as infectious diseases and cancer. Many hospital-based medical laboratory tests can now be done near the patient, ranging from basic blood glucose measurement to complex coagulation testing. Switching from conventional laboratory testing to POCT shortens the time to decision-making about further testing or treatment, as delays are no longer caused by specimen transport and preparation, and the test results are rapidly available at the point of care with better medical outcomes and lower costs. The development of a range of POCT devices that seek to provide the clinician with diagnostic test results more rapidly offer the opportunity to enhance the quality of care for the individual patient and the population at large. The future utilization of POCT will depend not only on technical advances, but also on developments in costs and reimbursement.The global hospital-based point-of-care testing (POCT) market segmentation is based on test type (critical care testing, drugs-of-abuse testing, hemostasis testing, cardiac marker testing, rapid infectious disease testing, other POC tests).
The global hospital-based point-of-care testing (POCT) market segmentation is based on test type (critical care testing, drugs-of-abuse testing, hemostasis testing, cardiac marker testing, rapid infectious disease testing, other POC tests).
The global hospital-based point-of-care testing market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global hospital-based point-of-care testing market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global hospital-based point-of-care testing market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.
Major players operating in the global hospital-based point-of-care testing market and profiled in this report include Abaxis, Abbott Laboratories, Accriva Diagnostics, Alere, Alfa Wassermann, Arkray, Danaher (Beckman Coulter, HemoCue, Radiometer), ELITech Group, Helena Laboratories, Instrumentation Laboratory, Menarini Diagnostics, Nova Biomedical, OraSure Technologies, Ortho Clinical Diagnostics, Panasonic Healthcare, Phamatech, Princeton BioMeditech, Quidel, Response Biomedical, Roche Diagnostics, Siemens Diagnostics, Trinity Biotech, and Trividia Health.